By G HossainPosted on October 9, 2026Posted in Pharmaceutical & Bio Science, UncategorizedTagged bio science career, blogs, business career news, career tips, job blog, job news, RJF Pharmaceutical Jobs With an internal non-opioid program nearing approval, Viatris is picking up Pacira BioSciences for a broader pain portfolio and the associated commercial infrastructure. Viatris inks $1.65B Pacira buyout to build non-opioid pain therapy business Post navigation How Abogen went from COVID hype to a $7.8B Novartis dealTRexBio, Retension raise $161.7M in IPOs; City, Iambic set proposed offering terms
